ArticleMicrobiologyOpen2026
Antimicrobial and Antibiofilm Activity of an Endophytic Fungus, Daldinia sp. Isolated From Avicennia officinalis.
Article in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Mangrove ecosystems are dynamic coastal habitats that support distinctive microbial communities capable of producing structurally diverse and biologically potent secondary metabolites. Among these, endophytic fungi residing asymptomatically within mangrove plants represent an underexplored resource with substantial potential for the discovery of novel antimicrobial agents. In this study, an endophytic fungus (Daldinia sp.) was isolated from the leaves of Avicennia officinalis collected from the mangrove forests of Goa. The ethyl acetate extract of the identified endophyte demonstrated significant antibacterial activity, with zones of inhibition ranging from 13.67 ± 0.57 to 17.33 ± 0.57 mm and minimum inhibitory concentrations ranging from 312.5 to 625 μg/mL against Escherichia coli and Shigella sp., following Clinical and Laboratory Standards Institute guidelines. Flow cytometry analysis of the extract showed 84.04% ± 5.89% and 62.15% ± 1.77% of cells stained with propidium iodide (PI) in E. coli and Shigella sp., respectively, indicating substantial membrane damage. The extract induced the generation of reactive oxygen species in E. coli and Shigella sp., leading to an increase in 2',7'-dichlorofluorescein (DCF) fluorescence intensity. Furthermore, the extract exhibited antibiofilm activity, inhibiting biofilm formation by 93.03% ± 1.67% in E. coli and 89.38% ± 0.91% in Shigella sp. Scanning electron microscopy also supports the antibiofilm and antibacterial potential of the extract, as evidenced by reduced biofilm density and visible physical damage to bacterial cells, respectively. The metabolite profiling indicates the presence of various metabolites with antimicrobial properties. Collectively, the findings underscore the potential of an isolated endophytic fungus as a valuable source of potent antibacterial and antibiofilm compounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.